Literature DB >> 25368177

Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.

Hai-Ying Zhang1, Ming Gao2, Qing-Rong Liu1, Guo-Hua Bi1, Xia Li3, Hong-Ju Yang1, Eliot L Gardner1, Jie Wu4, Zheng-Xiong Xi5.   

Abstract

Cannabinoid CB2 receptors (CB2Rs) have been recently reported to modulate brain dopamine (DA)-related behaviors; however, the cellular mechanisms underlying these actions are unclear. Here we report that CB2Rs are expressed in ventral tegmental area (VTA) DA neurons and functionally modulate DA neuronal excitability and DA-related behavior. In situ hybridization and immunohistochemical assays detected CB2 mRNA and CB2R immunostaining in VTA DA neurons. Electrophysiological studies demonstrated that activation of CB2Rs by JWH133 or other CB2R agonists inhibited VTA DA neuronal firing in vivo and ex vivo, whereas microinjections of JWH133 into the VTA inhibited cocaine self-administration. Importantly, all of the above findings observed in WT or CB1(-/-) mice are blocked by CB2R antagonist and absent in CB2(-/-) mice. These data suggest that CB2R-mediated reduction of VTA DA neuronal activity may underlie JWH133's modulation of DA-regulated behaviors.

Entities:  

Keywords:  CB2 receptor; JWH133; cannabinoid; cocaine; dopamine

Mesh:

Substances:

Year:  2014        PMID: 25368177      PMCID: PMC4246322          DOI: 10.1073/pnas.1413210111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Expression of CB2 cannabinoid receptor mRNA in adult rat retina.

Authors:  Q Lu; A Straiker; Q Lu; G Maguire
Journal:  Vis Neurosci       Date:  2000 Jan-Feb       Impact factor: 3.241

2.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.

Authors:  Fay Wang; John Flanagan; Nan Su; Li-Chong Wang; Son Bui; Allissa Nielson; Xingyong Wu; Hong-Thuy Vo; Xiao-Jun Ma; Yuling Luo
Journal:  J Mol Diagn       Date:  2012-01       Impact factor: 5.568

3.  Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.

Authors:  N E Buckley; K L McCoy; E Mezey; T Bonner; A Zimmer; C C Felder; M Glass; A Zimmer
Journal:  Eur J Pharmacol       Date:  2000-05-19       Impact factor: 4.432

4.  Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.

Authors:  María S García-Gutiérrez; Borja García-Bueno; Silvia Zoppi; Juan C Leza; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Increased vulnerability to cocaine in mice lacking dopamine D3 receptors.

Authors:  Rui Song; Hai-Ying Zhang; Xia Li; Guo-Hua Bi; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

6.  The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.

Authors:  Bogna M Ignatowska-Jankowska; Pretal P Muldoon; Aron H Lichtman; M Imad Damaj
Journal:  Psychopharmacology (Berl)       Date:  2013-05-08       Impact factor: 4.530

7.  Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons.

Authors:  M Marinelli; F J White
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

8.  Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.

Authors:  Auxiliadora Aracil-Fernández; José M Trigo; María S García-Gutiérrez; Antonio Ortega-Álvaro; Alexander Ternianov; Daniela Navarro; Patricia Robledo; Pere Berbel; Rafael Maldonado; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

9.  Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.

Authors:  W Schmidt; F Schäfer; V Striggow; K Fröhlich; F Striggow
Journal:  Neuroscience       Date:  2012-10-13       Impact factor: 3.590

10.  Impact of prefrontal cortex in nicotine-induced excitation of ventral tegmental area dopamine neurons in anesthetized rats.

Authors:  Die Zhang; Ming Gao; Dan Xu; Wei-Xing Shi; Boris S Gutkin; Scott C Steffensen; Ronald J Lukas; Jie Wu
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

View more
  129 in total

1.  Cannabinoid receptor with an 'identity crisis' gets a second look.

Authors:  Nala Rogers
Journal:  Nat Med       Date:  2015-09       Impact factor: 53.440

2.  Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.

Authors:  Matthew S Powers; Kristen R Breit; Julia A Chester
Journal:  Alcohol Clin Exp Res       Date:  2015-12       Impact factor: 3.455

Review 3.  The molecular and cellular mechanisms of depression: a focus on reward circuitry.

Authors:  Megan E Fox; Mary Kay Lobo
Journal:  Mol Psychiatry       Date:  2019-04-09       Impact factor: 15.992

4.  Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents.

Authors:  Chloe J Jordan; Zhi-Wei Feng; Ewa Galaj; Guo-Hua Bi; Ying Xue; Ying Liang; Terence McGuire; Xiang-Qun Xie; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

5.  Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.

Authors:  Ana Canseco-Alba; Norman Schanz; Branden Sanabria; Juan Zhao; Zhicheng Lin; Qing-Rong Liu; Emmanuel S Onaivi
Journal:  Behav Brain Res       Date:  2018-11-30       Impact factor: 3.332

Review 6.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

7.  Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Authors:  Patricia Del Cerro; Carolina Alquézar; Fernando Bartolomé; Pedro González-Naranjo; Concepción Pérez; Eva Carro; Juan A Páez; Nuria E Campillo; Ángeles Martín-Requero
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

8.  Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling.

Authors:  Stephanie C Gantz; Bruce P Bean
Journal:  Neuron       Date:  2017-03-02       Impact factor: 17.173

9.  Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.

Authors:  Lin Wang; Bing-Jin Liu; Yun Cao; Wei-Qi Xu; Dong-Sheng Sun; Meng-Zhu Li; Fang-Xiao Shi; Man Li; Qing Tian; Jian-Zhi Wang; Xin-Wen Zhou
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 10.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.